China Signals Commercial Insurance, Biotech And Foreign-Owned Hospitals As Policy Priorities

New Category C Drug List

The main 2025 policy priorities for China's government as outlined in an annual report will include the strengthening of commercial insurance for innovative drugs and opening up cell and gene therapy and the hospital sector to foreign investment.

Policy plans, goals and actions in 2025
China's 2025 government work report reiterated its focus on commercial insurance for innovative drugs, biotech and wholly foreign-owned hospitals. (Shutterstock)

The Chinese government’s 2025 Work Report, announced to the public on 5 March during the annual “Two Sessions” meeting that took place in Beijing over 5-11 March, lays out the country’s economic goals, main tasks and policy priorities for the year ahead.

Xu Hu

Read more by Xu Hu

Xu is a senior reporter and covers aspects on policy and regulations in China pharma industry within the APAC Pharma news team.

More from China

More from Pink Sheet